Browse Items (28 total)
- Tags: Microbial
Optimizing Antimicrobial Utilization: Job of a Steward, or Time for a Pilot?...Bush LM, Kaye D. Optimizing antimicrobial utilization: job of a steward, or time for a pilot? Clin Infect Dis 2017; 65:1195
Tags: 2017, Antiinfective Agents – Therapeutic Use, Bauer Karri A, Bush Larry M, Centers for Disease Control and Prevention (U.S.), Clinical Infectious Diseases, Communicable Diseases – Drug Therapy, Department of Internal Medicine, Drug Resistance, Drug Utilization, File Thomas M Jr, Goff Debra A, Hospital Programs, Infection – Drug Therapy, Infectious – Drug Therapy, Kaye Donald, Kullar Ravina, Leadership, Microbial, NEOMED College of Medicine, Pharmacists, Physicians, Pilots, Skin Diseases
The treatment of herpes simplex infections: an evidence-based review.
Tags: 2008, Acyclovir – Analogs and Derivatives, Acyclovir – Therapeutic Use, Antiviral Agents – Therapeutic Use, Archives of internal medicine, Brodell R T, Cernik C, Department of Internal Medicine, Drug Resistance, Evidence-Based, Gallina K, Herpes Genitalis – Drug Therapy, Herpes Simplex – Drug Therapy, Medical Practice, Microbial, NEOMED College of Medicine, Purines – Analogs and Derivatives, Purines – Therapeutic Use, Recurrence, Risk Factors, Valine, Valine – Therapeutic Use
Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Tags: 1991, Animals, Antibodies, Antiviral Agents/*pharmacology, Bromodeoxyuridine/*analogs & derivatives/pharmacology, DNA, Dobson A T, Docherty J J, Drug Resistance, Female, Fluorescent Antibody Technique, Humans, Intervirology, Jennings B A, Microbial, Monoclonal, Simplexvirus/*drug effects/enzymology/genetics, Thymidine Kinase/analysis/genetics, Trimble J J, Viral/analysis/biosynthesis, Virus Replication/drug effects
The epidemiology of respiratory tract infections.
Tags: 2000, 80 and over, Adolescent, Adult, Age Factors, Aged, Child, Community-Acquired Infections/epidemiology, Cross Infection/epidemiology, Department of Internal Medicine, Drug Resistance, Female, File T M, Humans, Incidence, Infant, Male, Microbial, Middle Aged, NEOMED College of Medicine, Newborn, Preschool, Respiratory Tract Diseases/*epidemiology/mortality/prevention & control, Risk Factors, Seminars in respiratory infections, United States/epidemiology
The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)
Tags: 2009, Antibiotics, Antibiotics – Therapeutic Use, Antiinfective Agents, Bacterial – Drug Therapy, Combination, Community-Acquired Infections – Drug Therapy, Department of Internal Medicine, Drug Resistance, Drug Therapy, File T M, Gram-Negative Bacteria, Human, Journal of Managed Care Pharmacy, Lactam – Therapeutic Use, Legionnaires' Disease – Drug Therapy, Macrolide – Therapeutic Use, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Quinolone – Therapeutic Use, Streptococcus
Optimal treatment strategies for community-acquired pneumonia: non-responders to conventional regimens.
Tags: 2001, Anti-Infective Agents/therapeutic use, Chemotherapy, Community-Acquired Infections/drug therapy/microbiology/pathology, Department of Internal Medicine, Drug Resistance, Female, File T M Jr, Humans, Male, Microbial, NEOMED College of Medicine, Ofloxacin/therapeutic use, Pneumonia/*drug therapy/etiology/pathology, Practice Guidelines as Topic, Suppuration/drug therapy/pathology, Treatment Failure
Treating CAP caused by penicillin-resistant S pneumoniae.
Community-acquired pneumonia.
Tags: 2003, Antibiotics – Therapeutic Use, Bacterial, Bacterial – Diagnosis, Bacterial – Drug Therapy, Bacterial – Microbiology, Bacterial – Prevention and Control, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections – Prevention and Control, Department of Internal Medicine, Disease Progression, Drug Resistance, File T M Jr, Immunocompetence, Lancet, Microbial, NEOMED College of Medicine, Pneumonia, Severity of Illness, Streptococcus – Drug Effects, Vaccines – Therapeutic Use
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
Tags: 2004, Antibiotics, Bacteria – Drug Effects, Benninger MS, Clinics in laboratory medicine, Combined – Therapeutic Use, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Jacobs MR, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Rhinosinusitis – Drug Therapy, Rhinosinusitis – Microbiology
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Antibiotics, Antibiotics – Administration and Dosage, Antiinfective Agents, Bacterial – Drug Therapy, Blasi F, Canada, Chest, Chidiac C, Community-Acquired Infections – Drug Therapy, Comparative Studies, Department of Internal Medicine, Drug Resistance, Europe, File T M Jr, Fluoroquinolone – Therapeutic Use, Garau J, Klugman K, Lactam – Therapeutic Use, Lode H, Lonks JR, Macrolide – Therapeutic Use, Mandell L, Microbial, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Ramirez J, United States, Yu V
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Antibiotics, Clinical Trials, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Etiology, Department of Internal Medicine, Drug Resistance, Drugs, File T M Jr, Immune System – Drug Effects, Inpatients, Macrolide – Pharmacodynamics, Macrolide – Therapeutic Use, Methicillin Resistance, Microbial, NEOMED College of Medicine, Nonexperimental Studies, Outpatients, Pneumonia – Drug Therapy, Pneumonia – Etiology, Practice Guidelines, Risk Assessment, Streptococcal Infections – Drug Therapy, Tan J S
The risk of prescribing antibiotics “just-in-case” there is infection.
Tags: 2018, adverse drug event, Antibiotic Prophylaxis, Antibiotics – Adverse Effects, Department of Internal Medicine, Drug Resistance, Drugs, Goff Debra A, Inappropriate Prescribing, JrFile Thomas M, Microbial, NEOMED College of Medicine, Patient Safety, Prescribing Patterns, Prescription, Professional Knowledge, Seminars in Colon & Rectal Surgery
Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
Tags: *Germ-Free Life, 2018, Alhamo M A, Animals, Anti-Bacterial Agents/administration & dosage, Beneficial microbes, Bifidobacterium longum/drug effects, Biodiversity, Biological, ciprofloxacin, Ciprofloxacin/administration & dosage/*pharmacology, Colony Count, Deblais L, Diarrhea/microbiology/physiopathology, Escherichia coli Nissle, Escherichia coli/*growth & development, Feces/microbiology, Fischer D D, gnotobiotic pigs, gut microbiota, Huang H-C, Intestines/*drug effects/microbiology/pathology/physiopathology, Kandasamy S, Kumar A, Langel S N, Microbial, Microbiota/*drug effects/physiology, Models, Paim F C, Probiotics/administration & dosage/*pharmacology, Rajashekara G, Rauf A, rotavirus, Rotavirus Infections/*microbiology/physiopathology/virology, Saif L J, Severity of Illness Index, Shao L, Swine, Virus Shedding/drug effects, Vlasova A N
Inclusion of chlorhexidine gluconate in alcohol-based presurgical hand antiseptics: Can a product be considered “superior” if it does not meet established efficacy requirements?...'Comparative efficacy of commercially available alcohol-based hand rubs and WHO-recommended hand rubs: formulation matters' Am J Infect Control 2012;40:521-5
Tags: 2013, American journal of infection control, Asepsis, Chlorhexidine, Colony Count, Cross Infection – Prevention and Control, Edmonds Sarah L, ETHANOL, Handwashing – Equipment and Supplies, Macinga David R, Microbial, Microbial Contamination, Product Evaluation, United States Food and Drug Administration
New recommendations for the treatment of tuberculosis.
Tags: 2005, Adult, Antitubercular Agents – Administration and Dosage, Antitubercular Agents – Adverse Effects, Antitubercular Agents – Pharmacodynamics, Antitubercular Agents – Therapeutic Use, Antitubercular Agents/adverse effects/pharmacology/*therapeutic use, Bacterial, Chemical and Drug Induced Liver Injury, Child, Current opinion in infectious diseases, Department of Internal Medicine, Drug Resistance, Female, Hepatitis, HIV Infections – Complications, HIV Infections/complications, Humans, Infant, Microbial, Multiple, Myers Joseph P, NEOMED College of Medicine, Practice Guidelines, Practice Guidelines as Topic, Preschool, Prescribing Patterns – Standards, Tuberculin Test, Tuberculosis – Drug Therapy, Tuberculosis – Epidemiology, Tuberculosis – Prevention and Control, Tuberculosis/*drug therapy/epidemiology/prevention & control, United States
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
Tags: *International Cooperation, *Intraabdominal Infections/diagnosis/drug therapy/microbiology, 2016, Abbott Iain J, Abu-Zidan Fikri M, Adesunkanmi Abdulrashid Kayode, Agresta Ferdinando, Al-Dahir Sara, Al-Hasan Majdi N, Althani Asma A, Ansaloni Luca, Ansari Shamshul, Ansumana Rashid, Anti-Infective Agents/*pharmacology, Augustin Goran, Bala Miklosh, Balogh Zsolt J, Baraket Oussama, Bassetti Matteo, Beltran Marcelo A, Bernhard Michael, Bhangu Aneel, Biffl Walter L, Boermeester Marja A, Brecher Stephen M, Brink Adrian J, Buyne Otmar R, Cainzos Miguel A, Cairns Kelly A, Camacho-Ortiz Adrian, Catena Fausto, Chandy Sujith J, Cherry-Bukowiec Jill R, Chichom-Mefire Alain, Coccolini Federico, Coimbra Raul, Colijn Caroline, Corcione Antonio, Corcione Francesco, Cui Yunfeng, Curcio Daniel, De Simone Belinda, De Waele Jan J, Delibegovic Samir, Demetrashvili Zaza, Department of Internal Medicine, Dhingra Sameer, Di Carlo Isidoro, Di Saverio Salomone, Diaz Jose J, Dillip Angel, Dogjani Agron, Dorj Gereltuya, Doyle Michael P, Drug Resistance, Dupont Herve, Eachempati Soumitra R, Eckmann Christian, Egiev Valery N, Elmangory Mutasim M, Enani Mushira Abdulaziz, Ferrada Paula, Fitchett Joseph R, Fraga Gustavo P, Ghnnam Wagih, Giamarellou Helen, Gkiokas George, Goldberg Staphanie R, Gomes Carlos Augusto, Gomi Harumi, Griffiths Ewen A, Guessennd Nathalie, Guzman-Blanco Manuel, Hansen Sonja, Haque Mainul, Hecker Andreas, Heizmann Wolfgang R, Herzog Torsten, Hodonou Adrien Montcho, Hong Suk-Kyung, Humans, Inaba Kenji, Isik Arda, Iskandar Katia, Ivatury Rao R, Junior Gerson Alves Pereira, Jusoh Asri Che, Kafka-Ritsch Reinhold, Kaplan Lewis J, Kapoor Garima, Karamarkovic Aleksandar, Kees Martin G, Kenig Jakub, Khokha Vladimir, Kiguba Ronald, Kim Peter K, Kirkpatrick Andrew W, Kluger Yoram, Knox Matthew C, Koike Kaoru, Kok Kenneth Y Y, Kong Victory, Kumar Anand, Labbate Maurizio, Labricciosa Francesco M, Laterre Pierre-Francois, Latifi Rifat, Lee Jae Gil, Lee Young Ran, Leone Marc, Leppaniemi Ari, Li Yousheng, Liang Stephen Y, Loho Tonny, Lowman Warren, Maegele Marc, Maier Ronald V, Malama Sydney, Marei Hany E, Martin-Loeches Ignacio, Marwah Sanjay, Massele Amos, May Addison K, Mazuski John E, McFarlane Michael, Melo Renato Bessa, Melotti Rita M, Mertz Dominik, Microbial, Microbial Sensitivity Tests, Montravers Philippe, Moore Ernest E, Moore Frederick A, Negoi Ionut, NEOMED College of Medicine, Nicolau David P, Nord Carl Erik, Ofori-Asenso Richard, Omari AbdelKarim H, Ordonez Carlos A, Ouadii Mouaqit, Piazza Diego, Prognosis, Pupelis Guntars, Rawson Timothy Miles, Rems Miran, Rizoli Sandro, Roberts Jason A, Rocha Claudio, Ruppe Etienne, Sakakushev Boris, Sanchez-Garcia Miguel, Sartelli Massimo, Sato Norio, Sawyer Rob G, Segovia Lohse Helmut A, Sganga Gabriele, Shelat Vishal G, Siribumrungwong Boonying, Soreide Kjetil, Soto Rodolfo, Spellberg Brad, Talving Peep, Tilsed Jonathan V, Timsit Jean Francois, Trueba Gabriel, Trung Ngo Tat, Uhl Waldemar, Ulrych Jan, van Goor Harry, Vereczkei Andras, Viale Perluigi, Vincent Jean-Louis, Viscoli Claudio, Vohra Ravinder S, Wani Imtiaz, Watkins Richard R, Weber Dieter G, World journal of emergency surgery : WJES, Wright Brian J, Xiao Yonghong, Yuan Kuo-Ching, Zachariah Sanoop K, Zahar Jean-Ralph, Zakrison Tanya L
Antipseudomonal penicillins.
Tags: 1995, Anti-Bacterial Agents/pharmacology, Department of Internal Medicine, Drug Resistance, File T M Jr, Humans, Microbial, Microbial Sensitivity Tests, NEOMED College of Medicine, Penicillins/adverse effects/pharmacokinetics/*therapeutic use, Pseudomonas Infections/*drug therapy, Pseudomonas/*drug effects, Tan J S, The Medical clinics of North America
Urinary tract infections in obstetrics and gynecology.
Tags: 1990, Anti-Bacterial Agents/pharmacology/*therapeutic use, Department of Internal Medicine, Drug Resistance, Escherichia coli/drug effects, Female, File T M Jr, Humans, Lactams, Microbial, NEOMED College of Medicine, Pregnancy, Quinolones/therapeutic use, Tan J S, The Journal of reproductive medicine, Urinary Tract Infections/*drug therapy
Streptococcus pneumoniae antimicrobial susceptibility testing.
Tags: *Drug Resistance, 2000, Anti-Bacterial Agents/*pharmacology, Child, Humans, Infant, Microbial, Microbial Sensitivity Tests/*methods, Preschool, Sensitivity and Specificity, Streptococcus pneumoniae/*drug effects/isolation & purification, The Pediatric infectious disease journal, Venglarcik J S 3rd
A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapies.
Tags: *Carbapenem-resistant Acinetobacter baumannii, *decolonization, *hospital-acquired infections, *therapies, *vaccination, 2018, Acinetobacter baumannii/drug effects/*isolation & purification, Acinetobacter Infections – Microbiology, Acinetobacter Infections – Therapy, Acinetobacter Infections/microbiology/*therapy, Animals, Anti-Bacterial Agents/pharmacology, Antibiotics – Pharmacodynamics, Bacterial, Carbapenems – Pharmacodynamics, Carbapenems/pharmacology, Department of Internal Medicine, Drug Resistance, Expert review of anti-infective therapy, Gram-Negative Aerobic Bacteria, Gram-Negative Aerobic Bacteria – Drug Effects, Humans, Microbial, Microbial Culture and Sensitivity Tests, Microbial Sensitivity Tests, NEOMED College of Medicine, Watkins Richard R
Statin Use Is Associated With a Lower Risk of Community-acquired Staphylococcus aureus Bacteremia.
Tags: 2017, Bacteremia – Risk Factors, Biofilms – Drug Effects, Cell Physiology – Drug Effects, Community-Acquired Infections – Drug Therapy, Department of Internal Medicine, Drug Resistance, Infectious Disease Alert, Microbial, NEOMED College of Medicine, Neutrophils, Risk Assessment, Simvastatin – Administration and Dosage, Staphylococcus Aureus – Drug Effects, Statins – Economics, Statins – Therapeutic Use, Watkins Richard R
Cranberry Capsules Are Not Effective in Preventing Bacteriuria with Pyuria in Elderly Women in Nursing Homes.
Tags: 2016, 80 and over, Aged, Antibiotics – Therapeutic Use, Capsules – Administration and Dosage – In Old Age, Confidence Intervals, Cranberry – Therapeutic Use – In Old Age, Department of Internal Medicine, Descriptive Statistics, Double-Blind Studies, Drug Resistance, Drug Utilization, Female, Fluid Intake, Gerontologic Care, Hospitalization, Inpatients, Internal Medicine Alert, Long Term Care, Microbial, Mortality, NEOMED College of Medicine, Nursing Home Patients, Odds Ratio, Plant Extracts – Therapeutic Use – In Old Age, RANDOMIZED controlled trials, Treatment Outcomes, Urinary Tract Infections – Prevention and Control – In Old Age, Watkins Richard R, Women's Health
The Growing Threat of Pyelonephritis Caused by Antibiotic-resistant Escherichia coli.
Tags: 2016, Adult, Antibiotics – Administration and Dosage, Antiinfective Agents, Biological Phenomena, Cell Culture Techniques, Community-Acquired Infections, Department of Internal Medicine, Drug Resistance, Emergency Service, Escherichia coli, Escherichia Coli Infections, Escherichia Coli Infections – Diagnosis, Female, Fluoroquinolone, Immunocompromised Host, Infectious Disease Alert, Male, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pregnancy, Pyelonephritis – Complications, Pyelonephritis – Diagnosis, Pyelonephritis – Etiology, Pyelonephritis – Risk Factors, Urinalysis, Watkins Richard R
The Concept of Healthcare-Associated Pneumonia Is Not Accurate for Predicting Antibiotic Resistant Pathogens.
Tags: 2014, Communicable Diseases – Diagnosis, Cross Infection – Diagnosis, Department of Internal Medicine, Drug Resistance, Human, Infectious Disease Alert, Meta Analysis, Methicillin-Resistant Staphylococcus aureus, Microbial, Microbiology, NEOMED College of Medicine, Nursing Homes, Patient Care, Pneumonia – Etiology, Pneumonia – Physiopathology, Primary Health Care, Pseudomonas Infections – Diagnosis, Serial Publications, Staphylococcal Infections, Watkins Richard R
Successful Decrease in Therapy Duration for Community-Acquired Pneumonia...including commentary by Watkins RR... this article originally appeared in the December 2012 issue of Infectious Disease Alert
Tags: 2013, Antibiotics – Therapeutic Use, Clostridium Infections – Risk Factors, Community-Acquired Pneumonia – Complications, Community-Acquired Pneumonia – Drug Therapy, Department of Internal Medicine, Drug Resistance, Hospital Medicine Alert, Microbial, NEOMED College of Medicine, Patient Discharge – Evaluation, Program Development, readmission, Research, Treatment Duration, United States Centers for Medicare and Medicaid Services, Watkins Richard R
Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis.
Tags: 2013, Antibiotics – Therapeutic Use, Bonomo Robert A, Carbapenems – Therapeutic Use, Department of Internal Medicine, Drug Resistance, Early Diagnosis, Enterobacteriaceae – Drug Effects, Enterobacteriaceae – Physiology, Enterobacteriaceae Infections – Diagnosis, Enterobacteriaceae Infections – Drug Therapy, Enterobacteriaceae Infections – Microbiology, Expert review of anti-infective therapy, Microbial, NEOMED College of Medicine, Watkins Richard R
On the path to untreatable infections: colistin use in agriculture and the end of 'last resort' antibiotics.
Tags: *Agriculture, *Antibiotic resistance, *Colistin, *Drug Resistance, 2016, Agriculture, Animal Husbandry, Anti-Bacterial Agents/*therapeutic use, Antibiotics – Therapeutic Use, Bacterial, Bonomo Robert A, Colistin – Analogs and Derivatives, Colistin – Therapeutic Use, Colistin/analogs & derivatives/*therapeutic use, Comparative Studies, Department of Internal Medicine, Drug Resistance, Escherichia coli, Escherichia Coli – Physiology, Escherichia coli Proteins/genetics, Escherichia coli/genetics/*physiology, European Union, Evaluation Research, Expert review of anti-infective therapy, Human, Humans, Microbial, Multicenter Studies, Multiple, NEOMED College of Medicine, Proteins, Smith Tara C, Validation Studies, Watkins Richard R
Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Tags: 1994, Acyclovir/pharmacology, Amino Acid Sequence, Antiviral Agents/metabolism/*pharmacology, Base Sequence, Binding Sites, Bromodeoxyuridine/*analogs & derivatives/metabolism/pharmacology, Deoxyuridine/analogs & derivatives/pharmacology, DNA, Docherty J J, Drug Resistance, Herpesvirus 1, Human/drug effects/*enzymology/genetics, Humans, Kinetics, Microbial, Molecular Sequence Data, Phosphonoacetic Acid/pharmacology, Phosphorylation, Point Mutation/genetics, Sequence Analysis, The Journal of general virology, Thymidine Kinase/genetics/metabolism, Thymidine/metabolism, Vidarabine/pharmacology, Wilber B A